Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Roundtable Seeks Targeted Proposals

by Linda R. Raber
September 17, 2007 | A version of this story appeared in Volume 85, Issue 38

The ACS Green Chemistry Institute (GCI) Pharmaceutical Roundtable is seeking applications for its 2008 research grant program.

The formal Request for Proposals is available on the ACS GCI Pharmaceutical Roundtable website: chemistry.org/greenchemistryinstitute/pharma_roundtable.html. The application deadline is Oct. 12. Contact gcipr@acs.org with questions. Proposals are sought from academic institutions worldwide for work on these targeted research areas:

◾ Amide formation, avoiding poor atom economy reagents
◾ OH activation for nucleophilic substitution
◾ Amide reduction without hydride reagents
◾ Safe and environmentally friendly Mitsunobu reactions
◾ Oxidation/epoxidation reactions without the use of chlorinated solvents
◾ C-H activation of aromatics (crosscouplings avoiding the preparation of haloaromatics)
◾ Chiral amine synthesis (aldehyde or ketone + NH3 + 'X')
◾ Asymmetric hydrogenation of unfunctionalized olefins/enamines/imines
◾ Green fluorination methods under mild conditions
◾ N-centered chemistry, avoiding azides, hydrazine, et cetera
◾ Solventless reactor cleaning
◾ Green alternatives to polar aprotic solvents

The roundtable is a partnership with GCI and pharmaceutical corporations united by a shared commitment to integrate the principles of green chemistry and engineering into the business of drug discovery and production.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.